14M164: Abstracts: Infection-related Rheumatic Disease (2272–2275)

Abstract Moderator(s)

• 

  Anne Bass, MD

  Hospital for Special Surgery, Weill Cornell Medicine
  New York, NY, United States

  Disclosure(s): No financial relationships to disclose
• 

  Julie Paik, MD, MHS

  Johns Hopkins University
  Baltimore, MD, United States

  Disclosure(s): Alexion Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Argenx: Consultant (Ongoing); Kezar Inc: Consultant (Ongoing); Pfizer Inc: Consultant (Ongoing), Grant/Research Support (Ongoing); Roivant: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)

Oral abstract session.

Presentations:

• 5:00 PM – 5:10 PM Eastern Time

  Temporal Trends in COVID-19 Outcomes Among Patients with Systemic Autoimmune Rheumatic Diseases: From the First Wave to Omicron
  

  Presenting Author: Yumeko Kawano, MD – Brigham and Women's Hospital
• 5:10 PM – 5:15 PM Eastern Time

  Q&A
  
• 5:15 PM – 5:25 PM Eastern Time

  Waning Vaccine Response After Primary Vaccine Series: Results from the Covid19 Vaccine Response in Rheumatology Patients (COVER) Study
  

  Presenting Author: Amy Mudano, MPH – University of Alabama at BIrmingham
• 5:25 PM – 5:30 PM Eastern Time

  Q&A
  
• 5:30 PM – 5:40 PM Eastern Time

  Factors Associated with Disease Flare Following SARS-CoV-2 Vaccination in People with Inflammatory Rheumatic and Musculoskeletal Diseases – Results from the Physician-Reported EULAR Coronavirus Vaccine (COVAX) Registry
  

  Presenting Author: Bayram Farisogullari, MD – Hacettepe University, Department of Internal Medicine Faculty of Medicine, Division of Rheumatology
• 5:40 PM – 5:45 PM Eastern Time

  Q&A
  
• 5:45 PM – 5:55 PM Eastern Time

  Three Dose SARS-CoV-2 Vaccination Is Associated with Reduced Risk of Breakthrough COVID-19 During Omicron Wave in Patients with Autoimmune Diseases
  

  Presenting Author: Caoilfhionn M. Connolly, MD, MSc – Johns Hopkins University School of Medicine
• 5:55 PM – 6:00 PM Eastern Time

  Q&A